tretazicar has been researched along with Necrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bangma, CH; Irvine, AS; Kraaij, R; Lipinski, KS; Mills, KH; Mountain, A; Pelech, S; Todryk, SM | 1 |
Dexter, MT; Djeha, AH; Hulme, A; Kerr, DJ; Mountain, A; Searle, PF; Wrighton, CJ; Young, LS | 1 |
2 other study(ies) available for tretazicar and Necrosis
Article | Year |
---|---|
Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Cell Line, Tumor; Genetic Therapy; Genetic Vectors; HSP70 Heat-Shock Proteins; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Necrosis; Nitroreductases; Prostatic Neoplasms; Proteomics | 2006 |
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954.
Topics: Animals; Apoptosis; Aziridines; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Head and Neck Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Nitroreductases; Prodrugs; Remission Induction; Time Factors; Tumor Cells, Cultured | 2000 |